Basel, Switzerland

Lucien Craps

This inventor holds 1 USPTO granted patent. Top assignee: Sandoz Ltd., (Sandoz Ag). Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lucien Craps. Retrieved from https://idiyas.com/inventor/lucien-craps

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lucien Craps: Innovator in Organic Compounds

Introduction

Lucien Craps is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of organic chemistry, particularly in the development of novel active agents for medical applications. His work is characterized by a focus on innovative solutions for common health issues.

Latest Patents

Lucien Craps holds a patent for organic compounds that involve unique combinations of active agents. His invention specifically concerns a combination of 1-methyl-2-[2-(α-methyl-p-chlorodiphenylmethyloxy)ethyl]pyrrolidine and a non-toxic sympathicomimetic agent that has a peripheral vasoconstrictive effect. This invention is particularly useful in the treatment of rhinitis, showcasing his commitment to improving healthcare through innovative chemistry. He has 1 patent to his name.

Career Highlights

Craps is associated with Sandoz Ltd., a prominent company in the pharmaceutical industry. His role at Sandoz has allowed him to collaborate with other experts in the field and contribute to the development of effective medical treatments. His work has been instrumental in advancing the understanding of organic compounds and their applications in medicine.

Collaborations

Due to space constraints, the details of collaborations will not be included.

Conclusion

Lucien Craps is a distinguished inventor whose work in organic compounds has the potential to significantly impact the treatment of rhinitis. His innovative approach and dedication to research exemplify the spirit of invention in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…